SECURITIES AND EXCHANGE COMMISSION

================================================================================
                             Washington, D.C. 20549

                             ----------------------

                                    FORM 10-Q

(Mark One)

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
     ACT OF 1934 for the quarterly period ended September 30, 1998

                                       OR

[  ] TRANSITION  REPORT  PURSUANT  TO  SECTION  13 OR  15(d)  OF THE  SECURITIES
     EXCHANGE ACT OF 1934 for the transition period from __________ to _________


                        Commission file number: 000-22673



                            SCHICK TECHNOLOGIES, INC.
             (Exact name of registrant as specified in its charter)

            Delaware                                           11-3374812
(State or other jurisdiction of                              (I.R.S. Employer
 incorporation or organization)                           Identification Number)
                                                                           



            31-00 47th Avenue                                     11101
       Long Island City, New York                               (Zip Code)
(Address of principal executive offices)

       Registrant's telephone number, including area code: (718) 937-5765


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days. Yes [ X ] No [ ]

As of November 6, 1998,  9,998,953  shares of common  stock,  par value $.01 per
share, were outstanding.

================================================================================


<PAGE>


                            SCHICK TECHNOLOGIES, INC.

                                TABLE OF CONTENTS


PART I.  FINANCIAL INFORMATION:
         Item 1.  Financial Statements:

                  Consolidated Balance Sheet as of September 30, 1998 
                  and March 31, 1998 ................................... Page 1

                  Consolidated Statement of Operations for the three and
                  six months ended September 30, 1998 and 1997 ......... Page 2

                  Consolidated Statement of Cash Flows for the six
                  months ended September 30, 1998 and 1997.............. Page 3

                  Notes to Consolidated Financial Statements ........... Page 4

         Item 2.  Management's Discussion and Analysis of Financial 
                     Condition  And Results of Operations............... Page 6
PART II.  OTHER INFORMATION:
         Item 2.  Changes in Securities and Use of  Proceeds............ Page 9
         Item 4.  Submission of Matters to a Vote of Security Holders    Page 10
         Item 6.  Exhibits and Reports on Form 8-K...................... Page 10
SIGNATURE............................................................... Page 11
EXHIBIT 27.............................................................. Page 12




<PAGE>

PART I.  Financial Information
Item 1.  Financial Statements

                            Schick Technologies, Inc.
                           Consolidated Balance Sheet
                      (In thousands , except share amounts)

<TABLE>
<CAPTION>
                        Assets                               September 30,      March 31,
                                                                 1998             1998
                                                                -------          -------
                                                             (unaudited)
<S>                                                             <C>              <C>    
Current assets
  Cash and cash equivalents                                     $ 2,409          $ 6,217
  Short-term investments                                          7,069           14,022
  Accounts receivable, net of allowance for doubtful
   accounts of  $700 and $200,  respectively                     16,125           10,173
  Inventories                                                    16,803           12,152
  Prepayments and other current assets                            1,481              746
                                                                -------          -------
         Total current assets                                    43,887           43,310

Equipment, net                                                    7,207            5,801
Investments                                                       1,250            1,000
Other assets                                                      1,266            1,214
Deferred tax asset                                                  413              349
                                                                -------          -------

         Total assets                                           $54,023          $51,674
                                                                =======          =======

        Liabilities and Stockholders' Equity

Current liabilities
  Accounts payable and accrued expenses                         $ 7,828          $ 7,010
  Accrued salaries and commissions                                1,242            1,473
  Provision for warranty obligations                                278              245
  Income taxes payable                                               --              144
  Deferred revenue                                                  373              362
  Deposits from customers                                           536              331
                                                                -------          -------
         Total current liabilities                               10,257            9,565


Commitments                                                          --               --

Stockholders' equity
  Preferred stock ($.01 par value; 2,500,000 shares
   authorized, none issued and outstanding)                          --               --
  Common stock ($.01 par value; 25,000,000 shares
   authorized; 9,996,123 and 9,992,057 shares issued
   and outstanding)                                                 100              100
  Additional paid-in capital                                     41,208           41,204
  Retained earnings                                               2,458              805
                                                                -------          -------
         Total stockholders' equity                              43,766           42,109

            Total liabilities and stockholders' equity          $54,023          $51,674
                                                                =======          =======
</TABLE>

The  accompanying  notes are an integral  part of these  consolidated  financial
statements.


                                       1
<PAGE>


                            Schick Technologies, Inc.
                      Consolidated Statement of Operations
                    (In thousands, except per share amounts)
                                   (unaudited)

<TABLE>
<CAPTION>
                                                   Three months ended                     Six months ended
                                                       September 30,                        September 30,
                                                --------------------------           --------------------------
                                                  1998              1997               1998              1997
                                                --------          --------           --------          --------
<S>                                             <C>               <C>                <C>               <C>     
Revenues, net                                   $ 14,236          $  8,224           $ 30,216          $ 14,264
Cost of sales                                      6,935             3,867             14,152             6,698
                                                --------          --------           --------          --------
           Gross profit                            7,301             4,357             16,064             7,566
                                                --------          --------           --------          --------


Operating expenses
  Selling and marketing                            4,642             2,088              8,799             3,884
  General and administrative                       1,732               854              3,082             1,731
  Research and development                           834               968              1,866             1,607
  Patent litigation settlement                        --                --                 --               600
                                                --------          --------           --------          --------
     Total operating expenses                      7,208             3,910             13,747             7,822
                                                --------          --------           --------          --------

    Income (loss) from operations                     93               447              2,317              (256)
                                                --------          --------           --------          --------

Other income (expense)
   Interest income                                   180               449                422               498
   Interest expense                                   --                (8)                --               (51)
                                                --------          --------           --------          --------

     Total other income (expense)                    180               441                422               447
                                                --------          --------           --------          --------

     Income before income taxes                      273               888              2,739               191
                                                --------          --------           --------          --------

Provision (benefit)for income taxes                  103              (122)             1,086              (122)
                                                --------          --------           --------          --------


Net income                                      $    170          $  1,010           $  1,653          $    313
                                                ========          ========           ========          ========


Basic earnings  per share                       $   0.02          $   0.10           $   0.17          $   0.03
                                                ========          ========           ========          ========

Diluted  earnings  per share
                                                $   0.02          $   0.10           $   0.16          $   0.03
                                                ========          ========           ========          ========
</TABLE>


The  accompanying  notes are an integral  part of these  consolidated  financial
statements.


                                       2
<PAGE>


                            Schick Technologies, Inc.
                      Consolidated Statement of Cash Flows
                                 (In thousands)
                                   (unaudited)

<TABLE>
<CAPTION>
                                                                 Six months ended September 30,
                                                                 ------------------------------
                                                                    1998                1997
                                                                 ----------          ----------
<S>                                                               <C>                <C>     
Net cash flows from operating activities:
Net income                                                        $  1,653           $    313
Adjustments to reconcile net income to net cash
   used in operating activities
   Depreciation and amortization                                       887                298
   Stock and option grant compensation                                  --                 11
   Accrued interest on investments                                    (201)               (37)
Changes in assets and liabilities:
  Accounts receivable                                               (5,952)            (2,160)
  Inventories                                                       (4,651)            (4,573)
  Prepayments and other current assets                                (551)               (41)
  Other assets                                                        (138)               (59)
  Deferred income taxes                                                (64)              (122)
  Accounts payable and accrued expenses                                620              3,376
  Income taxes payable                                                (144)                --
  Deferred revenue                                                      11                107
  Deposits from customers                                              205                (62)
  Accrued interest on notes payable                                     --               (102)
                                                                  --------           --------
           Net cash used in operating activities                    (8,325)            (3,051)
                                                                  --------           --------

Cash flows from investing activities:
  Capitalization of software development costs                        (182)               (39)
  Purchases of held-to-maturity investments                        (10,561)           (15,440)
  Proceeds from maturities of held-to-maturity
   investments                                                      17,712              1,434
  Business acquisition                                                  --             (1,450)
  Purchase of minority interest in Photobit Corporation               (250)              (994)
  Capital expenditures                                              (2,206)            (1,886)
                                                                  --------           --------
     Net cash provided by (used) in investing activities             4,513            (18,375)
                                                                  --------           --------

Cash flows from financing activities:
  Proceeds from sale of common stock                                    --             33,548
  Repayment of notes payable                                            --             (1,513)
  Proceeds from exercise of common stock options                         4                 --
  Principal payments on capital lease obligations                       --                (11)
                                                                  --------           --------
    Net cash provided by financing activities                            4             32,024
                                                                  --------           --------

Net increase (decrease) in cash and cash equivalents                (3,808)            10,598
Cash and cash equivalents at beginning of period                     6,217              1,710
                                                                  --------           --------

Cash and cash equivalents at end of period                        $  2,409             12,308
                                                                  ========           ========
</TABLE>


The  accompanying  notes are an integral  part of these  consolidated  financial
statements.


                                       3
<PAGE>


                            Schick Technologies, Inc.
             Notes to Consolidated Financial Statements (unaudited)
               (in thousands, except share and per share amounts)
--------------------------------------------------------------------------------

1.   Basis of Presentation

     The consolidated  financial  statements of Schick  Technologies,  Inc. (the
     "Company")  have  been  prepared  in  accordance  with  generally  accepted
     accounting  principles for interim  financial  information and the rules of
     the Securities and Exchange Commission (the "SEC") for quarterly reports on
     Form  10-Q,  and  do  not  include  all of  the  information  and  footnote
     disclosures  required  by  generally  accepted  accounting  principles  for
     complete  financial   statements.   These  statements  should  be  read  in
     conjunction with the audited  consolidated  financial  statements and notes
     thereto for the year ended March 31, 1998 included in the Company's  Annual
     Report on Form 10-K.

     In the  opinion of  management,  the  accompanying  unaudited  consolidated
     financial  statements  include  all  adjustments   (consisting  of  normal,
     recurring  adjustments)  necessary  for a fair  presentation  of results of
     operations for the interim  periods.  The results of operations for the six
     months ended  September  30, 1998,  are not  necessarily  indicative of the
     results to be expected for the full year ending March 31, 1999.

     The  consolidated  financial  statements  of the Company,  at September 30,
     1998,   include  the   accounts  of  the  Company  and  its  wholly   owned
     subsidiaries. All significant intercompany balances have been eliminated.

2.   Inventories

     Inventories  at September  30, 1998 and March 31, 1998 are comprised of the
     following:

                                              September 30,         March 31,
                                                 1998                  1998
                                                -------              -------
        Raw materials                           $ 6,190              $ 7,108
        Work-in-process                           6,050                3,466
        Finished goods                            4,563                1,578
                                                -------              -------
        
              Total inventories                 $16,803              $12,152
                                                =======              =======

3.   Initial Public Offering

     In July 1997,  the Company  completed  its  initial  public  offering  (the
     "IPO"),  selling  2,012,500 shares of common stock at a price of $18.50 per
     share  providing gross proceeds to the Company of $37,231 and net proceeds,
     after underwriting  discounts and commissions and offering expenses payable
     by the Company, of $33,508.

4.   Patent Litigation Settlement

     In July 1997,  the Company in  connection  with the  settlement  of certain
     pending patent  litigation  involving a United States patent  directed to a
     display  for  digital   dental   radiographs,   was  granted  a  worldwide,
     non-exclusive  fully paid license covering such patent in consideration for
     a payment by the Company of $600.  The Company  expensed the license fee in
     the quarter ended June 30, 1997.




                                       4
<PAGE>


                            Schick Technologies, Inc.
             Notes to Consolidated Financial Statements (unaudited)
               (In thousands, except share and per share amounts)
--------------------------------------------------------------------------------

5.   Earnings (Loss) Per Share

     Effective  December 31, 1997,  the Company  adopted  statement of Financial
     Accounting  Standards  No.  128,  "Earnings  per Share"  ("FAS  128") which
     requires presentation of basic earnings per share ("Basic EPS") and diluted
     earnings  per share  ("Diluted  EPS").  Basic EPS is  computed  by dividing
     income available to common stockholders by the  weighted-average  number of
     common shares  outstanding  during the period.  Diluted EPS gives effect to
     all dilutive  potential common shares  outstanding  during the period.  The
     computation  of  Diluted  EPS  does  not  assume  conversion,  exercise  or
     contingent exercise of securities that would have an antidilutive effect on
     earnings.  Earnings  per share for the  three and six month  periods  ended
     September  30,1997  have been  restated  for the  adoption of FAS 128.  The
     adoption of FAS 128 did not have a significant impact on the loss per share
     for the periods ended September 30, 1997.

     The computation of basic earnings per share and diluted  earnings per share
     for the three- and six-month  periods ended September 30, 1998 and 1997 are
     as follows:

<TABLE>
<CAPTION>
                                                       Three months ended              Six months ended
                                                          September 30,                  September 30,
                                                  ---------------------------     ---------------------------
                                                      1998            1997            1998            1997
                                                  -----------     -----------     -----------     -----------
<S>                                               <C>             <C>             <C>             <C>        
Net income available to common  stockholders      $       170     $     1,010     $     1,653     $       313
                                                  ===========     ===========     ===========     ===========
Weighted average shares outstanding
   for basic earnings per share                     9,992,566       9,969,731       9,992,521       8,968,980
Dilutive effect of stock options and warrants         361,893         463,143         372,401         232,837
                                                  -----------     -----------     -----------     -----------

Weighted average shares outstanding
   for diluted earnings per share                  10,354,459      10,432,874      10,364,922       9,201,817

Basic earnings per share                          $      0.02     $      0.10     $      0.17     $      0.03
                                                  ===========     ===========     ===========     ===========
Diluted earnings per share                        $      0.02     $      0.10     $      0.16     $      0.03
                                                  ===========     ===========     ===========     ===========
</TABLE>

6.   Investment in Photobit

     On July 14,  1998,  the  Company  invested an  additional  $250 in Photobit
     Corporation,   a  developer  of  complementary   metal-oxide  semiconductor
     ("CMOS"), active-pixel ("APS") imaging technology. As of September 30, 1998
     the Company's  investment in Photobit  Corporation  amounts to $1,250.  The
     Company  is the  exclusive  licensee  of the  APS  technology  for  medical
     applications and utilizes the technology in both its  bone-mineral  density
     assessment  device and certain  components  of its  computed  dental  x-ray
     imaging system.


                                       5
<PAGE>

Item 2.  Management's Discussion and Analysis of Financial
         Condition and Results of Operations

This Quarterly Report on Form 10-Q contains  forward-looking  statements  within
the  meaning of Section  27A of the  Securities  Act of 1933,  as  amended,  and
Section 21E of the Securities Exchange Act of 1934, as amended.  Actual results,
events and  circumstances  could differ  materially from those set forth in such
statements due to various  factors.  Such factors include the changing  economic
and competitive conditions in the medical and dental digital radiography market,
regulatory  approvals,  technological  developments,  protection  of  technology
utilized by the Company,  patent infringement  claims and other litigation,  and
further risks and  uncertainties,  including those detailed in Exhibit 99 to the
Company's Annual Report on Form 10-K and in the Company's other filings with the
Securities and Exchange Commission.

General

The Company  designs,  develops and  manufactures  digital  imaging  systems and
devices  for the dental and  medical  markets.  In the field of  dentistry,  the
Company has developed,  and currently  manufactures  and markets,  an intra-oral
digital  radiography  system.  The  Company has also  developed  a bone  mineral
density assessment device to assist in the diagnosis of osteoporosis,  which was
introduced  in  December  of 1997.  The  Company is also  developing  large-area
radiographic imaging devices for digital mammography.

Results of Operations

Net revenue for the three  months  ended  September  30,  1998,  increased $ 6.0
million (73%) to $14.2 million from $8.2 million during the comparable period of
fiscal 1998. Net revenue for the six months ended September 30, 1998,  increased
$ 16.0 million  (112%) to $30.2 million from $14.3 million during the comparable
period  of fiscal  1998.  The  strong  growth  is  attributable  to sales of the
Company's   AccuDEXA(TM)  bone  mineral  density  assessment  device  which  was
introduced in December 1997 combined with  increased unit sales of the Company's
CDR(TM) dental products resulting from increased market awareness and broadening
sales  distribution.  The increase in unit CDR(TM) volume is partially offset by
lower  average  selling  prices and an  increased  level of sales to dealers and
distributors.  Sales volume for the six months ended September 30, 1998 was also
positively  impacted by a supply interruption of a component used to manufacture
CDR(TM)  dental  products  during the fourth quarter of fiscal 1998 which pushed
shipment on  approximately  $2.5 million of CDR(TM)  sales orders into the first
quarter of fiscal 1999.  Sales volume for the three months ended  September  30,
1998 was negatively  impacted by $2.5 million of in-process orders that were not
shipped at the end of the second quarter  resulting in lower than expected sales
volume for the quarter.

Cost of sales for the three months ended  September  30,  1998,  increased  $3.1
million (79%) to $6.9 million (48.7% of net revenue) from $3.9 million (47.0% of
net revenue) for the comparable period of fiscal 1998. Cost of sales for the six
months ended September 30, 1998,  increased $7.5 million (111%) to $14.2 million
(46.8% of net revenues)  from $6.7 million  (47.0% of net  revenues)  during the
comparable  period of fiscal 1998. The increase in cost of sales as a percentage
of revenue for the three month  period ended  September  30, 1998 as compared to
the same period in fiscal 1998 is the result of an increase in certain  indirect
labor expenses related to a  reclassification  of Quality Control and Inspection
personnel  from R&D to  production.  The  Company  also  recognized  a charge of
$100,000 related to excess and slow moving  inventory and incurred  royalties on
technology utilized in the AccuDEXA(TM) and, in fiscal 1999, for certain CDR(TM)
dental products.

Selling and marketing  expenses for the three months ending  September 30, 1998,
increased  $2.6 million  (122%) to $4.6 million (32.6% of net revenue) from $2.1
million (25.4% of net revenue) for the comparable period of fiscal 1998. Selling
and marketing  expenses for the six months ended  September 30, 1998,  increased
$4.9 million  (127%) to $8.8 million  (29.1% of net revenues)  from $3.9 million
(27.2% of net  revenues)  during  the  comparable  period of fiscal  1998.  This
increase was  attributable  principally  to the hiring and training of new sales
representatives  as the Company  continued  to increase the size of its national
sales force and its promotional  programs to obtain greater market awareness and
to develop market strategies for new products.


                                       6
<PAGE>

General and  administrative  expenses for the three months ended  September  30,
1998,  increased $0.9 million (103%) to $1.7 million (12.2% of net revenue) from
$0.9 million  (10.4% of net revenue) for the  comparable  period of fiscal 1998.
General and administrative expenses for the six months ended September 30, 1998,
increased  $1.4 million (78%) to $3.1 million (10.2 % of net revenues) from $1.7
million (12.1% of net revenues) during the comparable period of fiscal 1998. The
increase in  administrative  costs is  attributable  primarily  to the hiring of
administrative personnel,  personnel-related  spending such as recruiting and an
increase in the Company's allowance for doubtful accounts.

Research and development expenses for the three months ended September 30, 1998,
decreased  $0.1 million  (14.0%) to $0.8 million (5.9% of net revenue) from $0.9
million  (11.8% of net  revenue)  for the  comparable  period  of  fiscal  1998.
Research and  development  expenses for the six months  ended  September,  1998,
increased $0.3 million  (16.1%) to $1.9 million (6.2% of net revenues) from $1.6
million  (11.3% of net revenues) for the  comparable  period of fiscal 1998. The
decrease in costs for the three-month  period ended September 30, 1998 primarily
reflects  lower  spending on testing  materials and services and the transfer of
research and development employees to the quality control department.

In July 1997, the Company,  in connection with the settlement of certain pending
patent  litigation  involving a United States  patent  directed to a display for
digital dental  radiographs,  was granted a worldwide,  non-exclusive fully paid
license  covering such patent in  consideration  for a payment by the Company of
$600  thousand.  The company  expensed that license fee during the quarter ended
June 30, 1997.

Interest  income  decreased to $180 thousand in the three months ended September
30, 1998 from $449 thousand in the  comparable  period of fiscal 1998.  Interest
income for the six months ended  September  1998 decreased to $422 thousand from
$498  thousand  for the  comparable  period  of fiscal  1998.  The  decrease  is
attributable   to  lower   cash   balances   and   investments   in   short-term
interest-bearing  securities  that  were  purchased  with  the  proceeds  of the
Company's Initial Public Offering (the "IPO").  Interest expense of $51 thousand
for the six month period ended September  30,1997 were principally  attributable
to a loan from Merck & Co. Inc. that was repaid upon consummation of the IPO.

Liquidity and Capital Resources

Net  proceeds  from the  July  1997 IPO were  approximately  $33.5  million.  At
September 30, 1998,  the Company had $2.4 million in cash and cash  equivalents,
$7.1 million in  short-term  investments  and $33.6  million in working  capital
compared  to $6.2  million  in cash  and  cash  equivalents,  $14.0  million  in
short-term investments and $33.7 million in working capital at March 31, 1998.

During the six months ended September 30, 1998, cash used in operations was $8.3
million compared to $3.1 million used in operations during the comparable period
of fiscal 1998. The increased cash used in operations is primarily  attributable
to increases in the Company's inventory and accounts receivable levels. Accounts
receivable  increased  from $10.2  million at March 31, 1998 to $16.1 million at
September 30, 1998 due to the increase in sales,  extended payment terms granted
to certain foreign and domestic  distributors and, primarily,  to an increase in
the average days outstanding.  The Company has recently implemented a program to
improve its accounts  receivable  collection  efforts and expects its days sales
outstanding  to decrease in future  periods.  The  increase in inventory of $4.7
million from $12.2  million at March 31, 1998 to $16.8  million at September 30,
1998 is primarily  attributable  to a work in process and finished goods buildup
in  anticipation  of sales volume during the quarter ended December 31, 1998 and
to the delay in shipment of the second quarter in-process orders.

The  Company's  capital  expenditures  during  the  six-month  period  were $2.2
million.  Capital  expenditures  during the six-month period included  leasehold
improvements, computers, and production equipment. The Company's planned capital
expenditures  for the remainder of fiscal 1999 are  approximately  $1.0 million,
primarily  for  computer  equipment,   leasehold   improvements  and  production
equipment.  Management  currently  believes that existing capital  resources are
adequate  to meet its  current  cash  requirements.  There can be no  assurance,
however,  that  changes in the  Company's  plans or other events  affecting  the
Company's   operations  will  not  result  in  accelerated  or  unexpected  cash
requirements.



                                       7
<PAGE>

Year 2000 Compliance

GENERAL

As the century concludes,  the Company is aware of the risks associated with the
Year 2000  computer  problem.  The Year 2000  problem is the result of  computer
programs  being  written  using  two  digits  rather  than  four to  define  the
applicable  year.  A  computer  program  that has date  sensitive  software  may
recognize  a date using  "00" as the year 1900  rather  than the year  2000.  If
systems  fail to process  date  information  correctly  when the year changes to
2000, many problems could occur.

The Company has  established a Y2K Task Force that is currently  evaluating  the
Company's  potential  for  Year  2000  related  problems,  with  respect  to the
Company's information technology ("IT") and non-information  technology systems.
The Y2K Task Force program  includes  three phases:  (1) an assessment  phase to
identify Year 2000 issues;  (2) a modification  phase to correct any area of the
Company's  business  which is not Year 2000  compliant;  and (3) a test phase to
confirm that all systems work  successfully.  The Company's  potential  problems
focus on three key areas of business operations:  products and services provided
to the Company by  third-party  vendors;  systems used by the Company to run its
business internally; and the Company's product line.

The Company has been  sending a Y2K Survey to its vendors in order to  determine
if their  operations  and the products  and services  they provide are Year 2000
compliant.  The responses  the Company  receives to the Y2K Survey will help the
Company  evaluate the extent to which it may be  vulnerable  to its vendors' own
Year 2000 issues.  Where  practicable,  the Company will attempt to mitigate its
risks with  respect to vendors  that are not Year 2000  compliant  and may,  for
example,  seek  alternative  sources of  supplies.  However,  Year 2000  related
failures  by vendors  remain a  possibility  and could  have a material  adverse
impact on the Company's results of operations or financial condition.

The Company is currently in the process of evaluating  the  capabilities  of its
internal  systems to process the Year 2000 correctly.  The Company believes that
most vendor-developed software which it utilizes in its internal operations will
be made Year  2000  compliant  before  the end of 1999  through  vendor-provided
updates or  replacements  with other Year 2000 compliant  hardware and software.
Additionally,  the  Company is testing its  internally  developed  software  and
hardware that are included in the products sold to customers.  Such  assessments
are  expected to be  completed  by early  calendar  1999.  If  modifications  or
conversion to existing  software or conversion to new software become  necessary
and modifications or conversions are not made, or are not completed timely,  the
Year 2000 issue could have a material adverse effect on the Company's  business,
financial condition and results of operations.

COSTS

The total  costs  associated  with  required  modifications  to become Year 2000
compliant are not expected to be material to the Company's  financial  position.
Current  estimated  costs  for the Y2K  Task  Force  program  are  approximately
$250,000;  however,  such  costs are  subject  to change as a result of  ongoing
evaluation  of the  extent  of the Year  2000  problem  at the  Company  and its
suppliers and affiliates.  As of the current date,  costs incurred in connection
with the Y2K Task Force program have been insignificant.

RISKS

The  Company  is  developing  specific  contingency  plans in the event that the
Company's  Year 2000  issues  are not  resolved  prior to time  that any  system
failures or  interruptions  in day-to-day  business  operations could occur. The
contingency plans are evolving as the Year 2000 assessment progresses.

Due to the general uncertainty  inherent in the Year 2000 problem,  resulting in
part from the  uncertainty of the Year 2000 readiness of third parties with whom
the Company  relies on, the Company is unable to  determine at this time whether
the  consequences  of Year 2000 failures will have a material  adverse impact on
the Company's  results of operations  but the Company  believes  that,  with the
completion  of  the  project  as  scheduled,   the  possibility  of  significant
interruptions of normal operations should be reduced.


                                       8
<PAGE>

PART II  OTHER INFORMATION


Item 2.  Changes in Securities and Use of Proceeds

(c) On September 16, 1998,  Francis Chucker elected to make a cashless surrender
of Warrants exercisable to purchase 6,720 shares of common stock for an exercise
price of $7.86 per share and in return  received  3,557 shares of the  Company's
Common Stock. Such issuances were pursuant to section 4(2) of the Securities Act
of 1933, as amended.

(d) On July 7, 1997, the Company's  initial public offering (the  "Offering") of
1,750,000  shares of its common  stock,  $.01 par value per share  (the  "Common
Stock") closed. The Company's  registration  statement on Form S-1 (Registration
No. 333-33731) was declared effective by the Securities and Exchange  Commission
on  June  30,  1997.  As  part  of the  Offering,  the  Company  granted  to the
Underwriters  over-allotment  options to purchase up to 262,500 shares of Common
Stock  ("the  "Underwriters'  Option").  On  July  10,  1997,  the  underwriters
exercised the  Underwriters'  Option  purchasing  262,500 shares of Common Stock
from the Company.  The aggregate  offering  price of 2,012,500  shares of Common
Stock  registered  for the  account  of the  Company  pursuant  to the  Offering
(inclusive of the Underwriters' Option) was $37.2 million.

     The aggregate net proceeds received by the Company from the Offering and as
a  result  of  the  exercise  of  the  Underwriters'   Option,  after  deducting
underwriting  fees,  commissions  and expenses  were $33.5  million.  During the
period of July 1, 1997 through  September 30, 1998,  such net proceeds have been
applied as follows:  (i) $1.3  million  for  leasehold  improvements;  (ii) $4.8
million for  property,  plant,  and  equipment;  (iii) $1.5  million to purchase
certain assets of Keystone Dental X-Ray Corp.;  (iv) $1.3 million to purchase an
interest in Photobit,  Inc.;  (v) $1.5 million to pay the notes  payable and the
interest  thereon  to  Merck & Co.,  Inc.;  (vi)  $3.6  million  to  short  term
investments;  (vii) $1.7  million to money  market  investments;  and (viii) the
remaining $17.8 million was used for working capital  purposes.  None of the net
proceeds were paid, directly or indirectly, to directors,  officers, controlling
stockholders, or affiliates of the Company.


                                       9
<PAGE>

Item 4.  Submission of Matters to a Vote of Security Holders

     The Company held its annual  meeting on September  10, 1998.  The following
matters were voted upon at the meeting with the accompanying results:

1. Election of Directors:

                         Number of      Number of Votes
                         Votes For      Withheld Authority
                         ---------      ------------------
Howard Wasserman         7,306,408           535,844

Fred Levine              7,306,408           535,844

     The other  directors  of the  Company  will  continue  in office  for their
existing terms.  Mark I. Bane and Euval Barrekette serve in the class whose term
expires in 1999,  and David B. Schick and Allen  Schick serve in the class whose
term expires in 2000.  Upon the  expiration of the term of a class of directors,
the  members of such class will be elected  for  three-year  terms at the annual
meeting of stockholders held in the year in which such term expires.

2.  Approval of the  proposal to amend the  Corporation's  1996  Employee  Stock
Option  Plan to  increase  the number of shares of the  Company's  common  stock
issuable thereunder from 470,400 to 1,000,000:

Number of votes for:                         4,815,471

Number of votes against:                       439,156

Number of abstentions:                          22,775


3. Ratification of the selection of PricewaterhouseCoopers LLP as the Company's
independent accountants for the fiscal year ending March 31, 1999:

Number of votes for:                         7,757,571

Number of votes against:                        78,026

Number of abstentions:                           6,655


Item 6.  Exhibits and Reports on Form 8-K

(a)  Exhibits

     (27) Financial Data Schedule



                                       10
<PAGE>


                            SCHICK TECHNOLOGIES, INC.
                                    SIGNATURE


Pursuant  to the  requirement  of the  Securities  Exchange  Act  of  1934,  the
registrant  has duly  caused  this  Report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.


                                          SCHICK TECHNOLOGIES, INC.



Date:   November 14, 1998           By:  /S/ David B. Schick                    
                                         ---------------------------------------
                                                   David B. Schick
                                                   President and
                                                   Chief Executive Officer



                                    By:   /S/ Thomas E. Rutenberg               
                                         ---------------------------------------
                                                   Thomas E. Rutenberg
                                                   Director of Finance
                                                   (Principal Financial Officer)



                                       11